Artificial Intelligence in the Service of Medicine: Current Solutions and Future Perspectives, Opportunities, and Challenges.

Q2 Medicine

Clinica Terapeutica Pub Date : 2025-03-01 DOI:10.7417/CT.2025.5192

S Marinelli, L De Paola, M Stark, G Montanari Vergallo

{"title":"Artificial Intelligence in the Service of Medicine: Current Solutions and Future Perspectives, Opportunities, and Challenges.","authors":"S Marinelli, L De Paola, M Stark, G Montanari Vergallo","doi":"10.7417/CT.2025.5192","DOIUrl":null,"url":null,"abstract":"Objective: This article aims to identify the opportunities and risks of Artificial Intelligence tools (AIT) applied to clinical practice, while also reflecting on their impact on the doctor-patient relationship.Materials and methods: The authors conducted a systematic literature review following the PRISMA guidelines, selecting the period from 2019 to October 2024. Academic databases PubMed and Scopus were drawn upon by using the keywords and searchstrings \"artificial intelligence\", \"healthcare\", \"informed consent\", and \"doctor-patient relationship\" in titles, abstracts, and keywords.Results and discussion: AIT has proven useful in significantly reducing the time spent on bureaucratic tasks and minimizing errors compared to traditional medicine. However, their effectiveness is highly influenced by the quantity and quality of data used for training. Additionally, there is an issue with the transparency of the decision-making process because AIT and even their programmers are unable to explain their diagnostic and therapeutic recommendations. Therefore, human supervision of AI work is essential.Conclusions: The potential risks of AI for patient safety and personal data security necessitate that governments urge those involved in the production of AI tools to adhere to specific ethical standards developed with the participation of all stakeholders, including patients.","PeriodicalId":50686,"journal":{"name":"Clinica Terapeutica","volume":"176 Suppl 1(2)","pages":"77-82"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica Terapeutica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7417/CT.2025.5192","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: This article aims to identify the opportunities and risks of Artificial Intelligence tools (AIT) applied to clinical practice, while also reflecting on their impact on the doctor-patient relationship.

Materials and methods: The authors conducted a systematic literature review following the PRISMA guidelines, selecting the period from 2019 to October 2024. Academic databases PubMed and Scopus were drawn upon by using the keywords and searchstrings "artificial intelligence", "healthcare", "informed consent", and "doctor-patient relationship" in titles, abstracts, and keywords.

Results and discussion: AIT has proven useful in significantly reducing the time spent on bureaucratic tasks and minimizing errors compared to traditional medicine. However, their effectiveness is highly influenced by the quantity and quality of data used for training. Additionally, there is an issue with the transparency of the decision-making process because AIT and even their programmers are unable to explain their diagnostic and therapeutic recommendations. Therefore, human supervision of AI work is essential.

Conclusions: The potential risks of AI for patient safety and personal data security necessitate that governments urge those involved in the production of AI tools to adhere to specific ethical standards developed with the participation of all stakeholders, including patients.

查看原文本刊更多论文

医学服务中的人工智能：当前解决方案和未来前景、机遇和挑战。

目的：本文旨在识别人工智能工具（AIT）应用于临床实践的机会和风险，同时也反映了它们对医患关系的影响。材料和方法：作者根据PRISMA指南进行了系统的文献综述，选取时间为2019年至2024年10月。通过在标题、摘要和关键词中使用关键字和搜索字符串“人工智能”、“医疗保健”、“知情同意”和“医患关系”来利用学术数据库PubMed和Scopus。结果和讨论：与传统医学相比，AIT已被证明在显著减少花费在官僚任务上的时间和最大限度地减少错误方面是有用的。然而，它们的有效性受到用于训练的数据的数量和质量的高度影响。此外，决策过程的透明度也存在问题，因为AIT甚至他们的程序员都无法解释他们的诊断和治疗建议。因此，人类对人工智能工作的监督至关重要。结论：人工智能对患者安全和个人数据安全的潜在风险要求政府敦促参与生产人工智能工具的人员遵守包括患者在内的所有利益相关者参与制定的特定道德标准。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinica Terapeutica PHARMACOLOGY & PHARMACY-

CiteScore

2.50

自引率

0.00%

发文量

124

审稿时长

6-12 weeks

期刊介绍： La Clinica Terapeutica è una rivista di Clinica e Terapia in Medicina e Chirurgia, fondata nel 1951 dal Prof. Mariano Messini (1901-1980), Direttore dell''Istituto di Idrologia Medica dell''Università di Roma “La Sapienza”. La rivista è pubblicata come “periodico bimestrale” dalla Società Editrice Universo, casa editrice fondata nel 1945 dal Comm. Luigi Pellino. La Clinica Terapeutica è indicizzata su MEDLINE, INDEX MEDICUS, EMBASE/Excerpta Medica.